A sense-antisense RNA interaction promotes breast cancer metastasis via regulation of NQO1 expression

Bruce Culbertson1,2,3,4, Kristle Garcia1,2,3,4, Daniel Markett1,2,3,4

  • 1Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA.

Nature Cancer
|May 11, 2023
PubMed

Insights

A novel antisense RNA, NQO1-AS, drives breast cancer progression by upregulating NADPH quinone dehydrogenase 1 (NQO1). Inhibiting this pathway reduces lung metastasis and offers therapeutic potential for female breast cancer patients.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Antisense RNAs are abundant but their functions in human cells remain largely unknown.
  • Understanding the roles of these RNAs is crucial for advancing cancer research.

Purpose of the Study:

  • To profile antisense RNAs in breast cancer cell lines, specifically MDA-MB-231 and its lung metastatic derivative.
  • To identify and characterize novel antisense RNAs involved in cancer progression and metastasis.

Main Methods:

  • Profiling of antisense RNAs in distinct breast cancer cell lines.
  • Gene knockdown experiments targeting NQO1 and the identified antisense RNA (NQO1-AS).
  • In vivo mouse models to assess lung colonization and therapeutic interventions.

Main Results:

  • Identification of NQO1-AS, an antisense RNA that upregulates NADPH quinone dehydrogenase 1 (NQO1), promoting cancer progression.
  • Knockdown of NQO1 or NQO1-AS significantly reduced lung metastasis in a mouse model.
  • NQO1 was found to protect breast cancer cells against oxidative damage and ferroptosis, a vulnerability exploitable therapeutically.

Conclusions:

  • NQO1-AS plays a critical role in breast cancer progression by post-transcriptionally regulating its sense mRNA.
  • Targeting the NQO1 pathway, by inducing ferroptosis and inhibiting NQO1, presents a potential therapeutic strategy for lung-metastatic breast cancer.
  • The findings are primarily applicable to female breast cancer patients due to the use of female-origin disease models.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Translational Regulation01:29

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
46
Riboswitches01:56

Riboswitches

Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.2K